Simplex Trading, LLC Harrow Health, Inc. Transaction History

Simplex Trading, LLC

  • $2.98 Billion
  • Q2 2024

A detailed history of Simplex Trading, LLC transactions in Harrow Health, Inc. stock. As of the latest transaction made, Simplex Trading, LLC holds 22,916 shares of HROW stock, worth $1.01 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
22,916
Holding current value
$1.01 Million
% of portfolio
0.02%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 25, 2024
BUY
$10.0 - $21.64 $229,160 - $495,902
22,916 New
22,916 $478,000
Q3 2023

Nov 01, 2023
BUY
$14.03 - $22.08 $325,636 - $512,476
23,210 New
23,210 $333,000
Q1 2023

Apr 27, 2023
BUY
$13.84 - $21.46 $42,461 - $65,839
3,068 New
3,068 $64,000
Q3 2022

Nov 04, 2022
SELL
$6.57 - $24.88 $96,966 - $367,203
-14,759 Reduced 89.32%
1,764 $21,000
Q2 2022

Aug 03, 2022
BUY
$5.75 - $7.74 $39,882 - $53,684
6,936 Added 72.35%
16,523 $120,000
Q1 2022

May 02, 2022
BUY
$6.77 - $8.66 $64,903 - $83,023
9,587 New
9,587 $65,000
Q4 2020

Feb 02, 2021
SELL
$4.76 - $6.93 $6,664 - $9,702
-1,400 Closed
0 $0
Q3 2020

Oct 14, 2020
BUY
$4.71 - $7.36 $1,497 - $2,340
318 Added 29.39%
1,400 $7,000
Q2 2020

Jul 13, 2020
SELL
$3.61 - $6.47 $17,963 - $32,194
-4,976 Reduced 82.14%
1,082 $5,000
Q1 2020

Apr 29, 2020
SELL
$3.5 - $7.31 $20,125 - $42,032
-5,750 Reduced 48.7%
6,058 $23,000
Q4 2019

Feb 05, 2020
SELL
$4.6 - $7.88 $313,743 - $537,455
-68,205 Reduced 85.24%
11,808 $91,000
Q3 2019

Oct 15, 2019
BUY
$4.89 - $8.0 $391,263 - $640,104
80,013 New
80,013 $449,000

Others Institutions Holding HROW

# of Institutions
121
Shares Held
19.7M
Call Options Held
700K
Put Options Held
575K
View Full List

About HARROW HEALTH, INC.

HROW Quotes by TradingView
  • Ticker HROW
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 27,070,000
  • Market Cap $1.2B
  • Description
  • Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...
More about HROW
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email